344 related articles for article (PubMed ID: 4854386)
1. Standardization of forensic drug analyses.
Frank RS; Gunn JW
J Forensic Sci; 1974 Jan; 19(1):163-7. PubMed ID: 4854386
[No Abstract] [Full Text] [Related]
2. Report on the PQRI impurity characterization and quantification best practices survey.
Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
[No Abstract] [Full Text] [Related]
3. Public standards for drugs: reflections on their use by the professions and industry.
Miller LC
Hosp Formul; 1976 Mar; 11(3):151-5. PubMed ID: 1026682
[No Abstract] [Full Text] [Related]
4. Reporting drug defects.
Belson JJ
Hosp Formul; 1975 Feb; 10(2):78-9. PubMed ID: 10316674
[No Abstract] [Full Text] [Related]
5. USP general chapter <797> pharmaceutical compounding-sterile preparations.
Hung JC
J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
[No Abstract] [Full Text] [Related]
6. Pharmaceutical analysis: key to drug quality and control.
Florey KG; Brewer GA
Am Pharm; 1981 Aug; NS21(8):30-5. PubMed ID: 7270421
[No Abstract] [Full Text] [Related]
7. GMPs vs GCPs: United States Pharmacopeia General Chapters.
Allen LV
Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791
[No Abstract] [Full Text] [Related]
8. Strategies for the identification, control and determination of genotoxic impurities in drug substances: a pharmaceutical industry perspective.
Raman NV; Prasad AV; Ratnakar Reddy K
J Pharm Biomed Anal; 2011 Jun; 55(4):662-7. PubMed ID: 21193280
[TBL] [Abstract][Full Text] [Related]
9. [Quality control in the pharmaceutical industry].
Bretscher E
Pharm Acta Helv; 1972; 47(11):664-75. PubMed ID: 4657535
[No Abstract] [Full Text] [Related]
10. Overall impact of the regulatory requirements for genotoxic impurities on the drug development process.
Giordani A; Kobel W; Gally HU
Eur J Pharm Sci; 2011 May; 43(1-2):1-15. PubMed ID: 21420491
[TBL] [Abstract][Full Text] [Related]
11. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
Hung JC
J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
[No Abstract] [Full Text] [Related]
12. [Pharmacopeia and preparations for cutaneous application].
Esnault F; Etchegaray JP; Mallard C
Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S40-5. PubMed ID: 17563714
[No Abstract] [Full Text] [Related]
13. WHO expert committee on specifications for pharmaceutical preparations.
World Health Organ Tech Rep Ser; 1984; 704():1-54. PubMed ID: 6437087
[No Abstract] [Full Text] [Related]
14. Toward more effective drug regulation.
Schmidt AM
FDA Consum; 1975 Dec-1976 Jan; 9(10):27-9. PubMed ID: 10316532
[No Abstract] [Full Text] [Related]
15. [Standardization as a basis planning and administration in drug industry and pharmacy (II)].
Wagler M
Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874
[No Abstract] [Full Text] [Related]
16. Application of the equivalence test for analytical method transfers: testing precision using the United States Pharmacopoeia concept (1010).
Schepers U; Wätzig H
J Pharm Biomed Anal; 2006 Apr; 41(1):290-2. PubMed ID: 16338114
[TBL] [Abstract][Full Text] [Related]
17. Combating counterfeit drugs.
Lancet; 2008 May; 371(9624):1551. PubMed ID: 18468523
[No Abstract] [Full Text] [Related]
18. Securing the US pharmaceutical supply.
Somberg JC
Am J Ther; 2008; 15(3):197. PubMed ID: 18496255
[No Abstract] [Full Text] [Related]
19. Current regulatory issues regarding parenteral inspections.
Avallone H
J Parenter Sci Technol; 1989; 43(1):3-7. PubMed ID: 2926605
[No Abstract] [Full Text] [Related]
20. How good are our drugs?
Miller LC
Am J Hosp Pharm; 1970 May; 27(5):367-74. PubMed ID: 5422276
[No Abstract] [Full Text] [Related]
[Next] [New Search]
